SCM
IMMU

Stevens Capital Management’s Immunomedics Inc IMMU Stock Holding History

Stevens Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,111
Closed -$277K – 536
2019
Q4 		$277K Buy
+13,111
New +$231K 0.03% 464
2018
Q4 		– Sell
-46,733
Closed -$973K – 1010
2018
Q3 		$973K Buy
+46,733
New +$1.11M 0.04% 435

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stevens Capital Management's IMMU Position: Q1 2020 in Review

Stevens Capital Management sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 13,111 shares — an estimated $277K sold.

Stevens Capital Management first reported a position in IMMU in Q3 2018 and held it in 2 quarters. The position peaked at $973K in Q3 2018. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Stevens Capital Management reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 13,111 Immunomedics Inc shares in Q1 2020, an estimated $277K.
  • Stevens Capital Management first reported a position in Immunomedics Inc in Q3 2018 and held it in 2 quarters.
  • Stevens Capital Management's Immunomedics Inc position peaked at $973K in Q3 2018.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.